XML 392 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Collaboration and License Agreements (Tables)
 12 Months Ended
Sep. 30, 2024
Collaboration And License Agreements [Abstract]  
Schedule of Revenue
The following table provides a summary of revenue recognized:
Year Ended September 30,
202420232022
(in thousands)
GSK$2,685 $29,657 $124,764 
Horizon— 23,206 29,181 
Takeda866 162,516 85,834 
Janssen— 356 3,452 
Amgen— 25,000 — 
Total$3,551 $240,735 $243,231 
Schedule of Receivables and Contract Liabilities
The following table summarizes the balance of receivables and contract liabilities related to the Company’s collaboration and license agreements:
September 30,
20242023
(in thousands)
Receivables included in accounts receivable$— $— 
Contract liabilities included in deferred revenue$— $866